Musk Myasthenia Gravis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-11-10
Clinical Trial Update: Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis [Phase 1]
An open-label Phase 1 trial evaluating the safety of various MuSK-CAART dosing regimens for MuSK myasthenia gravis has completed.